研究报告 |
|
|
|
|
靶向B细胞并特异结合其分泌IL-10的重组融合蛋白的构建、表达和初步鉴定 * |
赵荣,陈含宇,黄春,章晓联,潘勤() |
武汉大学基础医学院免疫学系 病毒学国家重点实验室 湖北省过敏及免疫相关疾病重点实验室 武汉 430071 |
|
Construction, Expression and Identification of Recombinant Fusion Protein Specifically Targeting B Cells and Binding to IL-10 |
Rong ZHAO,Han-yu CHEN,Chun HUANG,Xiao-lian ZHANG,Qin PAN() |
School of Basic Medical Immunology, Hubei Province Key Laboratory of Allergy and Immunology,and Department of Immunology, State Key Laboratory of Virology, Medical Research Institute,Wuhan University, Wuhan 430071, China |
引用本文:
赵荣,陈含宇,黄春,章晓联,潘勤. 靶向B细胞并特异结合其分泌IL-10的重组融合蛋白的构建、表达和初步鉴定 *[J]. 中国生物工程杂志, 2018, 38(2): 1-6.
Rong ZHAO,Han-yu CHEN,Chun HUANG,Xiao-lian ZHANG,Qin PAN. Construction, Expression and Identification of Recombinant Fusion Protein Specifically Targeting B Cells and Binding to IL-10. China Biotechnology, 2018, 38(2): 1-6.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20180201
或
https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I2/1
|
[1] |
Sabat R, Grutz G, Warszawska K , et al. Biology of interleukin-10. Cytokine Growth Factor Rev, 2010,21(5):331-344.
doi: 10.1016/j.cytogfr.2010.09.002
|
[2] |
Yanaba K, Bouaziz J D, Haas K M , et al. A regulatory B cell subset with a unique CD1d hi CD5 + phenotype controls T cell dependent inflammatory responses . Immunity, 2008,28(5):639-650.
doi: 10.1016/j.immuni.2008.03.017
pmid: 18482568
|
[3] |
Jurlander J, Lai C F, Tan J , et al. Characterization of interleukin-10 receptor expression on B-cell chronic lymphocytic leukemia cells. Blood, 1997,89(11):4146-4152.
doi: 10.1007/s002770050304
pmid: 9166857
|
[4] |
Carter R H, Fearon D T . CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science, 1992,256(5053):105-107.
doi: 10.1126/science.1373518
pmid: 1373518
|
[5] |
Yuan-Qin Min . Targeting of envelope protein E2 antigen to B cells via CD19-Scfv for HCV vaccine design. Wuhan:Wuhan University, 2013,1.
|
[6] |
Ma Y, Xiang D, Sun J , et al. Targeting of antigens to B lymphocytes via CD19 as a means for tumor vaccine development. Immunol, 2013,190(11):5588-5599.
doi: 10.4049/jimmunol.1203216
pmid: 23630363
|
[7] |
Yanaba K, Bouaziz J D, Matsushita T , et al. The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals. Immunol, 2009,182(12):7459-7472.
doi: 10.4049/jimmunol.0900270
|
[8] |
Schlom J . Therapeutic cancer vaccines: current status and moving for-ward. Natl Cancer Inst, 2012,104(11):599-613.
doi: 10.1093/jnci/djs033
pmid: 3328421
|
[9] |
Zhang Y, Eliav Y, Shin S U , et al. B lymphocyte inhibition of anti-tumor response depends on expansion of Treg but is independent of B-cell IL-10 secretion. Cancer Immunol Immun, 2013,62(1):87-99.
doi: 10.1007/s00262-012-1313-6
pmid: 22772949
|
[10] |
Olkhanud P B, Damdinsuren B, Bodogai M , et al. Tumor evoked regulatory B cells promote breast cancer metastasis by converting resting C D 4 + T cells to T-regulatory cells . Cancer Res, 2011,71(10):3505-3515.
doi: 10.1158/0008-5472.CAN-10-4316
pmid: 3096701
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|